Fig. 9

Myci975 reversed TMEM44-AS1-promoted the growth of glioma cells .(A) CCK-8 assay of LN-18, U251, and NHA cells treated with DMSO or Myci975 at an indicated concentration. *P < 0.05, **P < 0.01 vs. DMSO. (B) CCK-8 assay of PN16 and MES23 treated with DMSO or Myci975 at an indicated concentration. *P < 0.05, **P < 0.01 vs. DMSO. (C-D) Colony formation assay of LN-18 and MES23 cells treated with DMSO or Myci975 at an indicated concentration. **P < 0.01 vs. DMSO. (E) CCK-8 assay of PN16 and SF126 cells transfected with TMEM44-AS1 plasmid following Myci975 treatment. **P < 0.01 vs. vector, ^##P < 0.01 vs. TMEM44-AS1. (F-G) Colony formation assay of PN16 and SF126 cells transfected with TMEM44-AS1 plasmid following Myci975 treatment. **P < 0.01 vs. vector, ^##P < 0.01 vs. TMEM44-AS1